The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...

Among key components of drive is digital ‘thikri pehra’, installation of night-vision CCTV cameras and sound recording ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...

If you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series ...

For instance, Boston Scientific in November 2019, announced the launch of two devices within the peripheral drug-eluting product portfolio during separate late-breaking clinical trial presentations at ...

Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...

FDA inspections are essential to ensuring the safety and quality of products in the food, pharmaceutical, and medical device industries. One of the experienced professionals in this field is John ...

A decade-long effort to curb illicit drug trafficking in the region was recently buttressed by an investment in new equipment ...

The new test, from Fujirebio Diagnostics, Inc., identifies a sticky brain plaque, known as beta-amyloid, that is a key marker ...

The U.S. Food and Drug Administration on Friday cleared the first blood test for the diagnosis of Alzheimer's disease.

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...